ghk cu clinical trial 2024 Before vs. after 3 months of GHK-Cu peptide therapy 🪄 • smoother texture, more even tone, and skin that looks healthier overall. Small peptide, big difference 💙 12 weeks in, and my

BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations

Sources: Eagleson KL, et al

In neuro-research, GHK-Cu has been reported to boost the expression of BDNF and VEGF, showing neuroprotective properties in models of oxidative stress and excitotoxicity

The analysis of fissure numbers per microscopy field across different experimental groups reveals significant variations in brain tissue morphology (Figure 8B, F (5, 30) = 48.51, p 0.05)

Moreover, our research opens the door for the potential application of HDTCM to multitargeted AD therapy